Healthcare provider profile · identity verified

Jason Daniel Byers, M.D.

Family Practice · COON RAPIDS, MN · NPI 1467488254

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	309	85
Levothyroxine Sodium	Levothyroxine Sodium	307	79
Lisinopril	Lisinopril	288	77
Omeprazole	Omeprazole	253	65
Amlodipine Besylate	Amlodipine Besylate	204	55
Rosuvastatin Calcium	Rosuvastatin Calcium	184	54
Simvastatin	Simvastatin	178	53
Hydrochlorothiazide	Hydrochlorothiazide	160	50
Losartan Potassium	Losartan Potassium	155	42
Tamsulosin Hcl	Tamsulosin Hcl	154	45
Metformin Hcl	Metformin Hcl	140	39
Tramadol Hcl	Tramadol Hcl	140	25
Metformin Hcl Er	Metformin Hcl	133	38
Trazodone Hcl	Trazodone Hcl	124	31
Atenolol	Atenolol	116	29
Gabapentin	Gabapentin	114	28
Metoprolol Tartrate	Metoprolol Tartrate	110	29
Metoprolol Succinate	Metoprolol Succinate	108	32
Glipizide Er	Glipizide	104	30
Pantoprazole Sodium	Pantoprazole Sodium	103	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	99	28
Albuterol Sulfate Hfa	Albuterol Sulfate	90	38
Prednisone	Prednisone	86	70
Furosemide	Furosemide	77	24
Alprazolam	Alprazolam	76	11
Eliquis	Apixaban	63	15
Sertraline Hcl	Sertraline Hcl	62	20
Famotidine	Famotidine	55	20
Potassium Chloride	Potassium Chloride	55	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	12
Allopurinol	Allopurinol	52	16
Zolpidem Tartrate	Zolpidem Tartrate	49	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	suppressed
Ezetimibe	Ezetimibe	46	suppressed
Warfarin Sodium	Warfarin Sodium	46	14
Clopidogrel	Clopidogrel Bisulfate	43	14
Pravastatin Sodium	Pravastatin Sodium	43	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	12
Triamcinolone Acetonide	Triamcinolone Acetonide	42	17
Azithromycin	Azithromycin	39	33
Tizanidine Hcl	Tizanidine Hcl	39	21
Fluticasone Propionate	Fluticasone Propionate	38	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	13
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Meloxicam	Meloxicam	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Jardiance	Empagliflozin	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Lorazepam	Lorazepam	30	suppressed
Glipizide	Glipizide	29	suppressed
Nystatin	Nystatin	29	12
Fluconazole	Fluconazole	27	suppressed
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	12
Hydroxyzine Pamoate	Hydroxyzine Pamoate	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Ozempic	Semaglutide	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Baclofen	Baclofen	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	17
Estradiol	Estradiol	18	suppressed
Finasteride	Finasteride	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Premarin	Estrogens, Conjugated	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Valacyclovir	Valacyclovir Hcl	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Timolol Maleate	Timolol Maleate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Cephalexin	Cephalexin	13	13
Donepezil Hcl	Donepezil Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Roflumilast	Roflumilast	13	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nitroglycerin	Nitroglycerin	12	11
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Naproxen	Naproxen	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error